Open Label Safety And Efficacy Study Of Pregabalin In Subjects With Nerve Pain Asociated With Human Immunodeficiency Virus (HIV) Neuropathy

Inclusion Criteria:

- Participation in the preceding A0081066 double-blind trial met the entry criteria for
that trial and completed A0081066 study through visit 7

Exclusion Criteria:

- Experienced serious adverse event during the A0081066 trial that was considered
related or possibly related to study medication by the investigator or sponsor

- non-compliant during A0081066 trial

- clinically significant or unstable medical condition both HIV-related and non-HIV
related including but not limited to, cardiac, pulmonary or hepatorenal disease that,
in the opinion of the investigator, would compromise participation in the study